Literature DB >> 31342172

Bladder Augmentation (Enterocystoplasty): the Current State of a Historic Operation.

Jeffrey Budzyn1, Hamilton Trinh1, Samantha Raffee1, Humphrey Atiemo2.   

Abstract

PURPOSE OF REVIEW: The goal of this paper was to evaluate the current use of enterocystoplasty, a historical operation for bladder dysfunction but with continued and increasing modern relevance. RECENT
FINDINGS: Since the advent of third line neuromodulation techniques for neurogenic and idiopathic overactive bladder (OAB), the usage of enterocystoplasty has decreased. However, this procedure continues to be utilized in pediatric urology patients and the most refractory OAB patients. Adult urologist should be familiar with this operative technique in an effort to manage pediatric patients transitioning to adulthood. Minimally invasive techniques for this surgical procedure have been described with very limited outcome data. It is important for all urologists to be familiar with enterocystoplasty, both technically and with the unique needs of these patients postoperatively. Further studies evaluating the outcomes of this procedure in idiopathic overactive bladder patients and efforts to standardize recommendations for neurogenic bladder patients will help guide care in the future.

Entities:  

Keywords:  Augmentation cystoplasty; Bladder augmentation; Enterocystoplasty; Neurogenic bladder; Overactive bladder

Mesh:

Year:  2019        PMID: 31342172     DOI: 10.1007/s11934-019-0919-z

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  4 in total

1.  Long-term survival after radical cystectomy and mesenteric lymph node dissection for squamous cell carcinoma arising from augmented bladder with lymph node metastasis: a case report.

Authors:  Takahiko Soma; Minato Yokoyama; Yusuke Uchida; Susumu Kirimura; Hajime Tanaka; Soichiro Yoshida; Yoh Matsuoka; Yasuhisa Fujii
Journal:  Int Cancer Conf J       Date:  2020-09-01

2.  Therapeutic potential of adipose-derived mesenchymal stem cell exosomes in tissue-engineered bladders.

Authors:  Tianli Yang; Feng Zhao; Liuhua Zhou; Jingyu Liu; Luwei Xu; Quanliang Dou; Zheng Xu; Ruipeng Jia
Journal:  J Tissue Eng       Date:  2021-03-31       Impact factor: 7.813

3.  Application of antibody-conjugated small intestine submucosa to capture urine-derived stem cells for bladder repair in a rabbit model.

Authors:  Yu-Ting Song; Yan-Qing Li; Mao-Xuan Tian; Jun-Gen Hu; Xiu-Ru Zhang; Peng-Cheng Liu; Xiu-Zhen Zhang; Qing-Yi Zhang; Li Zhou; Long-Mei Zhao; Jesse Li-Ling; Hui-Qi Xie
Journal:  Bioact Mater       Date:  2021-11-27

4.  Invasive poorly differentiated adenocarcinoma of the bladder following augmentation cystoplasty: a multi-institutional clinicopathological study.

Authors:  Joshua A Anderson; Andres Matoso; Belkiss I Murati Amador; Liang Cheng; Bradley A Stohr; Emily Chan; Adeboye O Osunkoya
Journal:  Pathology       Date:  2020-09-17       Impact factor: 5.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.